Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add filters








Language
Year range
1.
China Pharmacy ; (12): 1211-1215, 2023.
Article in Chinese | WPRIM | ID: wpr-973621

ABSTRACT

OBJECTIVE To investigate the effects of Angelica sinensis polysaccharide on the apoptosis of cardiomyocytes in diabetic KK-Ay mice. METHODS KK-Ay mice were randomly divided into model group, metformin group (200 mg/kg) and A. sinensis polysaccharide high-dose, medium-dose and low-dose groups (400, 200 and 100 mg/kg); C57BL/6J mice were included in blank group, with 8 mice in each group. Each group was given relevant medicine intragastrically or normal saline, once a day, for consecutive 4 weeks. After the final administration, the levels of fasting glucose, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and insulin (INS) were detected; the protein expressions of B-cell lymphoma 2 (Bcl-2), cleaved- caspase-3, apoptosis signal-regulated kinase 1 (ASK1), phosphorylated c-Jun N-terminal kinase (p-JNK), phosphorylated inositol- requiring enzyme 1α (p-IRE1α) in myocardium, and apoptosis in cardiomyocytes were also detected. RESULTS Compared with model group, the fasting glucose, TC and LDL-C content, apoptotic rate of cardiomyocyte, protein expressions of p-JNK and p- IRE1α, ASK1, cleaved-caspase-3 were significantly lower in the metformin group and A. sinensis polysaccharide medium-dose, high-dose groups; INS level and relative expression of Bcl-2 protein were significantly increased (P<0.05 or P<0.01). CONCLUSIONS A. sinensis polysaccharide can improve the levels of blood glucose and blood lipid and inhibit cardiomyocyte apoptosis in diabetic KK-Ay mice, and the mechanism may be related to the inhibition of IRE1/ASK1/JNK signaling pathway.

2.
Chinese Pharmacological Bulletin ; (12): 1252-1259, 2022.
Article in Chinese | WPRIM | ID: wpr-1014042

ABSTRACT

Aim To evaluate the effect of E-se extract on insulin resistance in KK-Ay mice with spontaneous type 2 diabetes anrl explore its mechanism.Methods Ten C57/6J mice were assigned to a normal control group.Fifty KK-Ay model mice were randomly divided into model group, positive control group ( rosiglita- zone, 2.67 mg • kg 1 ), and low- ( 0.75 g • kg 1 ) , medium- ( 1.50 g • kg 1 ) , and high-dose ( 3.00 g • kg ') E-se groups, with 10 mice in each group.All mice were measured for body weight and fasting blood glucose weekly, insulin tolerance on the 32nd day, and insulin after the last administration on the 35th day, and the insulin resistance/sensitivity indexes were calculated.The pancreas was stained by hematoxylin- eosin ( HE ).Islet cell apoptosis was detected by TUNEL staining.Glucagon-like peptide-1 ( GLP-1 ) was detected by immunohistochemistry.Results j j Compared with the model group, the E-se groups showed reduced body weight, fasting blood glucose, serum insulin concentration, and insulin resistance in¬dex, elevated insulin sensitivity index, decreased le¬sion grading score of pancreatic tissues and apoptosis percentage of islet cells, and increased content of GLP- 1 protein in pancreatic tissues.Conclusions E-se ex¬tract can improve insulin resistance by reducing serum insulin level, inhibiting islet cell apoptosis, and in¬creasing the sensitivity of the body to insulin.

3.
Drug Evaluation Research ; (6): 1389-1396, 2017.
Article in Chinese | WPRIM | ID: wpr-663955

ABSTRACT

Objective To study the effect and mechanism of Water extract from Jiangtang Decoction (WEJTD) on diabetes mellitus and diabetic nephropathy (DN) in spontaneous type 2 diabetes mellitus model KK-Ay mice.Methods Totally 50 KK-Ay mice were randomly divided into five groups:model group,metformin (positive drug,250 mg/kg) group,WEJTD low,medium and high dose (2,4,and 8 g/kg) group,with 10 C57BL/6J mice as normal group.The relative drugs were ig administered once a day for 12 weeks,and mice in control group and model group were perfused with distilled water of equal volume.After 12 weeks' oral administration,mice were put into metabolism cages,and the food-intake,water-intake and urine volume were calculated and collected.Blood were collected to detect the concentration of IL-6,ICAM-1 and TNF-α.Then mice were executed,and HE staining and PASM staining were used to check the effect of WEJTD on kidney.Western blotting and qRT-PCR were used to detect the concentration of PI3K,Akt,NF-κB,IL-6,ICAM-1 and TNF-α in kidney.Results WEJTD can alleviate the symptoms of diabetes,such as food ration,polydipsia and polyuria (P < 0.05,0.01,and 0.001);Relief the pathological changes of kidney and significantly decreased glycogen deposition (P < 0.001),down-regulate the increase of IL-6,ICAM-1 and TNF-α in serum and kidney (P < 0.05,0.01 and 0.001),up-regulate the phosphorylation of PI3K and Akt (P < 0.05,0.01,and 0.001),and inhibit the phosphorylation of NF-κB (P < 0.001).Conclusion WEJTD had positive effects on kidney morphology of KK-Ay,and the underlying mechanism might be related to the regulation of PI3K-Akt and NF-κB-mediated inflammation.

4.
Chinese Traditional and Herbal Drugs ; (24): 1611-1616, 2017.
Article in Chinese | WPRIM | ID: wpr-852849

ABSTRACT

Objective: To explore the effect of Gegen Qinlian Decoction (GGQLD) on LPS, TNF-α, IL-6, and intestinal flora in diabetic KK-Ay mice. Methods: C57BL/6J mice with ordinary feed were taken as the normal control group and orally administrated with equal distilled water. The KK-Ay mice fed with high-fat diet were divided into five groups: pioglitazone group, blank group (model group), high, medium, and low dose GGQLD group, and orally administrated with pioglitazone hydrochloride (5 mg/kg), distilled water, and GGQLD (crude drug 40, 13.3, and 4.44 g/kg), respectively. The oral administration for six groups lasted for four weeks. Tumor necrosis factor (TNF-α), interleukin 6 (IL-6), and endotoxin (LPS) levels in the plasma were determined by enzyme-linked immunosorbent assay (ELISA); Gut microbial communities were assayed by polymerase chain reaction (PCR) and PCR-denaturing gradient gel electrophoresis (PCR-DGGE) methods. Results: Compared with the model group, the LPS levels in the plasma of mice were significantly reduced by 15.61% and 14.48% respectively in the Gegenqinlian Decoction of high and medium dose group (P < 0.05), the IL-6 levels in plasma of mice were significantly reduced by 56.86%, 37.12% and 30.21% respectively in high, medium, and low dose GGQLD group (P < 0.05), and the TNF-α levels in plasma of mice were significantly reduced by 28.32%, 30.70%, and 23.42% respectively in high, medium, and low dose GGQLD group (P < 0.05). The number of DGGE bands in high dose group significantly increased, and by cloning, sequencing, and Blast analysis, Lactobacillus johnsonii only existed in the high dose group; The results showed that GGQLD could regulate the structure of intestinal flora in KK-Ay mice. Conclusion: The mechanisms of anti-diabetic effects of GGQLD in type 2 diabetic KK-Ay mice are probably related with the anti-inflammation and regulation of intestinal flora.

5.
Chinese Pharmaceutical Journal ; (24): 29-33, 2015.
Article in Chinese | WPRIM | ID: wpr-859330

ABSTRACT

OBJECTIVE: To observe the glucose tolerance and evaluate the hypoglycemic effect of MBX-2982 respectively in the normal mice and in the KK-Ay mice. And further pharmacokinetics investigation was experimented in rats. METHODS: The influence of glucose tolerance was evaluated in KM mice which underwent a single dose of MBX-2982. Body weight, fasting blood glucose, glucose tolerance, triglyceride, serum insulin were all tested in order to evaluate the hypoglycemic effect on KK-Ay mice. The pharmacokinetics of MBX-2982 suspension and solution were investigated in rats to calculate the oral bioavailability. RESULTS: The blood glucose of each test point were all reduced after MBX-2982 (3, 10, 30 mg · kg-1) were administered orally to KM mice. After MBX-2982 (10, 30 mg · kg-1) treatment to KK-Ay mice for 4 weeks, the fasting blood glucose and triglyceride were significantly reduced and the serum insulin was remarkably increased. Meanwhile the area under glucose curve was significant reduced of 30 mg · kg-1. After oral administration of MBX-2982 (4 mg · kg-1) in rats, the oral bioavailability of suspension (0.4% CMC) and solution (DMSO-Cremopor EL-NS = 1:1:8) were 35.2% and 98.2% receptively. CONCLUSION: Animal experiment results show that the MBX-2982 as a GPR119 agonists had a good hypoglycemic effect. The absolute bioavailability of the solution is closed to 100%, which is higher than that of suspension.

6.
World Science and Technology-Modernization of Traditional Chinese Medicine ; (12): 1150-1156, 2015.
Article in Chinese | WPRIM | ID: wpr-476938

ABSTRACT

This article was aimed to study the effect ofQiwei granules on the podocyte in KK-Ay mice kidney. The 28 8-week-old male KK-Ay mice were randomly divided into the model group, low-dosage, middle-dosage and high-dosageQiwei granule group. Eight C57BL/6J mice were used as the normal control. The general conditions, blood glucose and 24 h albuminuria were recorded in the experiment. After 10-week treatment, renal indexes including serum creatinine and urea nitrogen were measured. The kidneys of mice were collected and measured. The hematoxylin and eosin (HE), Masson’s Trichrome, and periodic acid-Schiff (PAS) were used on renal tissues of mice. The immunohistochemical staining for WT-1 was made. Software analysis was combined in the calculation of renal podocyte amount. Western blot was used in the detection of nephrin protein expressions in the kidney of mice. RT-PCR was used in the detection of nephrin mRNA expression. The results showed that compared with the model group, the body weight, blood glucose, 24 h albuminuria and the serum creatinine were obviously decreased after 10-week treatment ofQiwei granules. It can effectively improve the glomerular mesangial proliferation and preserve the podocyte number. Meanwhile, after the treatment ofQiwei granules, the nephrin protein expression and mRNA expression were obviously higher than the model group. It was concluded thatQiwei granules probably managed nephrin expression to improve the podocyte injury in the diabetic nephropathy of KK-Ay mice.

7.
Chinese Pharmacological Bulletin ; (12): 1575-1579, 2015.
Article in Chinese | WPRIM | ID: wpr-480654

ABSTRACT

Aim To find the material foundation of treatment for diabetes in Coptidis Rhizoma ( RC ) . Methods The antihyperglycemic effect of RC alka-loids ( berberine, coptisine, palmatine, epiberberine, and jatrorrhizine) was evaluated in spontaneity diabe-tes KK-Ay mice. Results After 40 days′ oral admin-istration ( 225 mg · kg-1 · d-1 , ig ) , berberine and coptisine significantly suppressed the elevated fasting blood glucose level and ameliorated the glucose toler-ance . Body weight gain of KK-Ay mice was significant-ly decreased in the epiberberine-treated group. Berber-ine improved insulin resistance and jatrorrhizine in-creased the SOD activity, decreased the MDA level. Conclusions These results indicate that the main an-tihypoglycemic effect constituents are berberine and coptisine, while they show different mechanisms. Pal-matine, epiberberine and jatrorrhizine display different potential roles in the treatment of diabetes. The meth-ylene-dioxy groups at the C-2 , C-3 , C-9 and C-10 po-sitions are indispensable for antihyperglycemic effect of RC alkaloids.

8.
Chinese Pharmaceutical Journal ; (24): 2177-2180, 2014.
Article in Chinese | WPRIM | ID: wpr-860093

ABSTRACT

OBJECTIVE: To study the effects tetrahydrocurcumin-solid dispersion on KK-AY mice. METHODS: C 57/6 J mice were used as controls, KK-Ay mice were randomly divided into model group, tetrahydrocurcumin-solid dispersion groups(100, 50, 15 mg · kg-1) and rosiglitazone group(2.67 mg · kg-1), gavage for 35 d, mouse weight, fasting blood glucose, oral glucose tolerance, serum insulin and blood lipid indexes were detected. RESULTS: The weight mice tetrahydrocurcumin-solid dispersion group (100 mg · kg-1) on twenty-first days administration began to decrease, and maintained at a low level during the administration; tetrahydrocurcumin-solid dispersion in each dose group showed impaired fasting blood glucose lowering from the fourteenth day after the administration began, and maintained at a low level during the administration, tetrahydrocurcumin-solid dispersion in each dose group can decrease postprandial blood glucose and AUC value; tetrahydrocurcumin-solid dispersion in each dose group can decrease the value TC, LDL-C, increase the insulin sensitivity index, tetrahydrocurcumin-solid dispersion in each dose group glycosylated serum protein values were decreased, while only in the 100 mg · kg-1 group was statistical significant differences compared with the model group. CONCLUSION: Tetrahydrocurcumin-solid dispersion, which can effectively reduce the blood glucose levels KK-AY mice, and has good effect on glucose metabolism, lipid metabolism. The mechanism action may be related to the increase insulin sensitivity.

SELECTION OF CITATIONS
SEARCH DETAIL